Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169173810> ?p ?o ?g. }
- W3169173810 endingPage "3320" @default.
- W3169173810 startingPage "3320" @default.
- W3169173810 abstract "Background: Neurotic disturbances, anxiety, neurosis-like disorders, and stress situations are widespread. Benzodiazepine tranquillizers have been found to be among the most effective antianxiety drugs. The pharmacological action of benzodiazepines is due to their interaction with the supra-molecular membrane GABA-a-benzodiazepine receptor complex, linked to the Cl-ionophore. Benzodiazepines enhance GABA-ergic transmission and this has led to a study of the role of GABA in anxiety. The search for anxiolytics and anticonvulsive agents has involved glutamate-ergic, 5HT-ergic substances and neuropeptides. However, each of these well-known anxiolytics, anticonvulsants and cognition enhancers (nootropics) has repeatedly been reported to have many adverse side effects, therefore there is an urgent need to search for new drugs able to restore damaged cognitive functions without causing significant adverse reactions. Objective: Considering the relevance of epilepsy diffusion in the world, we have addressed our attention to the discovery of new drugs in this field Thus our aim is the synthesis and study of new compounds with antiepileptic (anticonvulsant) and not only, activity. Methods: For the synthesis of compounds classical organic methods were used and developed. For the evaluation of biological activity some anticonvulsant and psychotropic methods were used. Results: As a result of multistep reactions 26 new, five-membered heterocyclic systems were obtained. PASS prediction of anticonvulsant activity was performed for the whole set of the designed molecules and probability to be active Pa values were ranging from 0.275 to 0.43. The studied compounds exhibit protection against pentylenetetrazole (PTZ) seizures, anti-thiosemicarbazides effect as well as some psychotropic effect. The biological assays evidenced that some of the studied compounds showed a high anticonvulsant activity by antagonism with pentylenetetrazole. The toxicity of compounds is low and they do not induce muscle relaxation in the studied doses. According to the study of psychotropic activity it was found that the selected compounds have an activating behavior and anxiolytic effects on the models of “open field” and “elevated plus maze” (EPM). The data obtained indicate the anxiolytic (anti-anxiety) activity of the derivatives of pyrimidines, especially pronounced in compounds 6n, 6b, and 7c. The studied compounds increase the latent time of first immobilization on the model of “forced swimming” (FST) and exhibit some antidepressant effect similarly to diazepam. Docking studies revealed that compound 6k bound tightly in the active site of GABAA receptor with a value of the scoring function that estimates free energy of binding (ΔG) at −7.95 kcal/mol, while compound 6n showed the best docking score and seems to be dual inhibitor of SERT transporter as well as 5-HT1A receptor. Conclusions: Тhe selected compounds have an anticonvulsant, activating behavior and anxiolytic effects, at the same time exhibit some antidepressant effect." @default.
- W3169173810 created "2021-06-22" @default.
- W3169173810 creator A5001016231 @default.
- W3169173810 creator A5005340417 @default.
- W3169173810 creator A5027428109 @default.
- W3169173810 creator A5041216662 @default.
- W3169173810 creator A5061224046 @default.
- W3169173810 creator A5072252984 @default.
- W3169173810 creator A5075727918 @default.
- W3169173810 creator A5085798055 @default.
- W3169173810 creator A5086912125 @default.
- W3169173810 creator A5089381420 @default.
- W3169173810 date "2021-06-01" @default.
- W3169173810 modified "2023-09-26" @default.
- W3169173810 title "Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2-d]pyrrolo[1,2-a]pyrimidines, Pyridofuro[3,2-d]pyrido[1,2-a]pyrimidines and Pyridofuro[3′,2′:4,5]pyrimido[1,2-a]azepines" @default.
- W3169173810 cites W1965061696 @default.
- W3169173810 cites W1970749433 @default.
- W3169173810 cites W1973386992 @default.
- W3169173810 cites W1981737096 @default.
- W3169173810 cites W1982371070 @default.
- W3169173810 cites W1987398739 @default.
- W3169173810 cites W1997872815 @default.
- W3169173810 cites W2003076573 @default.
- W3169173810 cites W2004241446 @default.
- W3169173810 cites W2008278052 @default.
- W3169173810 cites W2011505858 @default.
- W3169173810 cites W2014281284 @default.
- W3169173810 cites W2023116642 @default.
- W3169173810 cites W2037997999 @default.
- W3169173810 cites W2045920093 @default.
- W3169173810 cites W2052907531 @default.
- W3169173810 cites W2060874643 @default.
- W3169173810 cites W2067514640 @default.
- W3169173810 cites W2088042660 @default.
- W3169173810 cites W2092953670 @default.
- W3169173810 cites W2093115573 @default.
- W3169173810 cites W2101826413 @default.
- W3169173810 cites W2105649494 @default.
- W3169173810 cites W2109318635 @default.
- W3169173810 cites W2110858704 @default.
- W3169173810 cites W2124254332 @default.
- W3169173810 cites W2153558299 @default.
- W3169173810 cites W2171043072 @default.
- W3169173810 cites W2184730195 @default.
- W3169173810 cites W2463624255 @default.
- W3169173810 cites W2501045218 @default.
- W3169173810 cites W2950989085 @default.
- W3169173810 cites W2951079610 @default.
- W3169173810 cites W2952344329 @default.
- W3169173810 cites W3008872669 @default.
- W3169173810 cites W3107603707 @default.
- W3169173810 cites W4244915445 @default.
- W3169173810 doi "https://doi.org/10.3390/molecules26113320" @default.
- W3169173810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8198642" @default.
- W3169173810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34205930" @default.
- W3169173810 hasPublicationYear "2021" @default.
- W3169173810 type Work @default.
- W3169173810 sameAs 3169173810 @default.
- W3169173810 citedByCount "6" @default.
- W3169173810 countsByYear W31691738102022 @default.
- W3169173810 countsByYear W31691738102023 @default.
- W3169173810 crossrefType "journal-article" @default.
- W3169173810 hasAuthorship W3169173810A5001016231 @default.
- W3169173810 hasAuthorship W3169173810A5005340417 @default.
- W3169173810 hasAuthorship W3169173810A5027428109 @default.
- W3169173810 hasAuthorship W3169173810A5041216662 @default.
- W3169173810 hasAuthorship W3169173810A5061224046 @default.
- W3169173810 hasAuthorship W3169173810A5072252984 @default.
- W3169173810 hasAuthorship W3169173810A5075727918 @default.
- W3169173810 hasAuthorship W3169173810A5085798055 @default.
- W3169173810 hasAuthorship W3169173810A5086912125 @default.
- W3169173810 hasAuthorship W3169173810A5089381420 @default.
- W3169173810 hasBestOaLocation W31691738101 @default.
- W3169173810 hasConcept C15744967 @default.
- W3169173810 hasConcept C168258287 @default.
- W3169173810 hasConcept C169760540 @default.
- W3169173810 hasConcept C170493617 @default.
- W3169173810 hasConcept C185592680 @default.
- W3169173810 hasConcept C2775858608 @default.
- W3169173810 hasConcept C2776175493 @default.
- W3169173810 hasConcept C2778173252 @default.
- W3169173810 hasConcept C2778186239 @default.
- W3169173810 hasConcept C55493867 @default.
- W3169173810 hasConcept C71924100 @default.
- W3169173810 hasConcept C98274493 @default.
- W3169173810 hasConceptScore W3169173810C15744967 @default.
- W3169173810 hasConceptScore W3169173810C168258287 @default.
- W3169173810 hasConceptScore W3169173810C169760540 @default.
- W3169173810 hasConceptScore W3169173810C170493617 @default.
- W3169173810 hasConceptScore W3169173810C185592680 @default.
- W3169173810 hasConceptScore W3169173810C2775858608 @default.
- W3169173810 hasConceptScore W3169173810C2776175493 @default.
- W3169173810 hasConceptScore W3169173810C2778173252 @default.
- W3169173810 hasConceptScore W3169173810C2778186239 @default.
- W3169173810 hasConceptScore W3169173810C55493867 @default.
- W3169173810 hasConceptScore W3169173810C71924100 @default.
- W3169173810 hasConceptScore W3169173810C98274493 @default.
- W3169173810 hasIssue "11" @default.